Prudential PLC Lowers Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Prudential PLC decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 34.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 42,341 shares of the medical device company's stock after selling 22,063 shares during the period. Prudential PLC's holdings in Cooper Companies were worth $3,892,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Byrne Asset Management LLC purchased a new position in shares of Cooper Companies during the 4th quarter valued at approximately $33,000. OFI Invest Asset Management acquired a new position in Cooper Companies during the fourth quarter worth $34,000. New Age Alpha Advisors LLC purchased a new position in Cooper Companies during the fourth quarter valued at $38,000. West Financial Advisors LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $49,000. Finally, Atala Financial Inc purchased a new stake in shares of Cooper Companies during the fourth quarter worth about $51,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on COO. Stifel Nicolaus decreased their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Piper Sandler reiterated an "overweight" rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup decreased their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and an average target price of $110.25.

Remove Ads

Cooper Companies Trading Up 2.8 %

NASDAQ:COO traded up $2.09 on Friday, hitting $77.46. The stock had a trading volume of 2,672,239 shares, compared to its average volume of 1,394,314. The company has a fifty day moving average price of $84.64 and a two-hundred day moving average price of $94.63. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market cap of $15.49 billion, a price-to-earnings ratio of 39.72, a PEG ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.